Webinar videos

​Clinical incident management

The Ministry of Health funded the Australian Council for Healthcare Standards (ACHS) to conduct training with NADA members about all you need to know about clinical incident management. Under AOD-Core KPI 4 Clinical Incident Management, organisations are required to have a clinical incident management process in place to manage all clinical incidents, and to report serious clinical incidents.

Presenter: A/Professor Peter Hibbert, Program Manager, Australian Institute of Health Innovation, Faculty of Medicine, Macquarie University

Support document
Serious clinical incident report form [DOCX]

Engaging with families and significant others

Presenters: Dr Suzie Hudson and Tony Trimingham (Family Drug Support)

  • Learn about engaging with families and significant others of people with substance use issues
  • Be introduced to NADA’s Family Inclusive Practice eLearning modules

Depot buprenorphine

Depot buprenorphine is a new long acting formulation of an existing opioid pharmacotherapy, buprenorphine and is available now in specialist OST clinics and NSW Government run prisons. Watch this video recording with NSW Chief Addiction Medicine Specialist, Dr Tony Gill, to learn more about how this pharmacotherapy works and discuss the implications for people who receive this treatment.

Support documents

Treating the hype: supports and treatment responses for people impacted by methamphetamine use

Australian Institute of Health and Welfare data list methamphetamine use second only to alcohol as the most common drug of concern in clients attending AOD services in Australia. Whilst overall rates of methamphetamine use in Australia have remained stable in recent years, people who use methamphetamine are reporting higher rates of regular and dependent use, leading to complex physical, mental health and social problems. The role of treatment and other interventions is crucial in addressing these, with residential rehabilitation, withdrawal management and counselling making up the current treatment options. The evidence base for stimulant-specific interventions and treatment is modest, but building, recognising the need for effective support that acknowledges the frequent experience of discrimination with this substance. This presentation will discuss where the A)D sector goes from here…

Brought to you in partnership with Insight and NCCRED (National Centre for Clinical Research on Emerging Drugs).

NADAbase dashboards

NADA recently held webinar to train members on how to use, analyse and maximise the new NADAbase dashboards. Did you miss out? Watch the video recording below.

Engaging consumers: Tricky or transformational?

In this video recording, we delve into the role of language, consumers and research and hear consumers experiences of engagement. Watch to acquire insights into the significance of lived experience in relation to consumer participation, gain an understanding of the role which language can play regarding access and equity and increase your awareness about the developing role of consumers in research.

This webinar was brought to you in partnership with the Australasian Professional Society on Alcohol and Other Drugs and the Network of Alcohol and other Drugs Agencies.